Yüklüyor......
Current views on the pathogenesis and treatment of atopic dermatitis in adults. Experience with the JAK inhibitor baricitinib in patients with moderate to severe atopic dermatitis
Atopic dermatitis is a common, chronic, immunoinflammatory disease, the study of the pathogenesis of which has recently stepped forward and served as the impetus for the development of new drugs. For the last 10–15 years, in clinical practice, the choice of therapy for patients with moderate and sev...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
Remedium Group LLC
2022-04-01
|
| Seri Bilgileri: | Медицинский совет |
| Konular: | |
| Online Erişim: | https://www.med-sovet.pro/jour/article/view/6830 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|